drugset / Trial / NCT00000235

Alternate Day Buprenorphine Administration, Phase XII - 17

NCT00000235 ↗

CrossoverTreatment

Summary

The purpose of this study is to determine if six times daily buprenorphine dose is effective in achieving 120 hour buprenorphine dosing.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — —